S&P 500: 682.85 +0.2% NASDAQ 100: 601.30 -0.1% Dow Jones: 495.85 +0.1%

Organon & Co.

OGN Healthcare
$7.28 $-0.11 (-1.49%)
Market Cap: $1.89 B
Gurus Holding
7
Popularity Rank
#1042
% of Shares Held
5.18%
Net Activity (Q4 2025)
+$30.73 M

Guru Ownership Trend

Guru Analysis for Organon & Co. (OGN)

Organon & Co. (OGN), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $98.1 M.

Top institutional holders include Cliff Asness and Joel Greenblatt.

Institutional sentiment is currently Bullish. This is evidenced by a $30.73 M net inflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 105.2%. Conversely, Joel Greenblatt reduced exposure by 28.5%.

Key Holders

Top 5 by Value

$61.28 M
$19.03 M
$6.52 M
$4.7 M
$3.21 M

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$39.15 M
Total Buy Value
New Buys 2
Additions 3
-$8.42 M
Total Sell Value
Reductions 2
Sold Out 2

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
4
Net Buyers
5

FAQs for Organon & Co. (OGN)

Major holders include Cliff Asness ($61.28 M), Joel Greenblatt ($19.03 M), Ray Dalio ($6.52 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 13.47 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $30.73 M, with 5 managers increasing positions and 4 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 2 fully exited OGN. The total reported sell value was $8.42 M.

Yes, 2 managers opened new positions in OGN, and 3 increased their existing holdings. The total reported buy value was $39.15 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.03% Add 105.2% 8,570,958 $61.28 M Q4 2025
0.07% Reduce -28.5% 2,653,817 $19.03 M Q4 2025
0.02% Add 36.0% 909,225 $6.52 M Q4 2025
0.01% New Buy 655,731 $4.7 M Q4 2025
0.01% Reduce -9.4% 447,661 $3.21 M Q4 2025
0.02% New Buy 177,385 $1.27 M Q4 2025
0.00% Add 6.0% 59,878 $429,325 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form